BMJ · 1985 · 221 citations · 31 references
Life SciencesGeneticsPharmacotherapyCardiovascular GeneticsHuman GeneticsMedical GeneticsCardiovascular DiseaseCholesterol MetabolismFamilial HypercholesterolemiaLipid DisordersLipid-lowering TherapyLipoprotein MetabolismHeterozygous Familial HypercholesterolemiaHomozygous Familial HypercholesterolemiaPeak Serum ConcentrationPlasma Cholesterol LevelsTherapeutic Plasma Exchange
Plasma exchange was undertaken in five patients with homozygous familial hypercholesterolaemia at intervals of two weeks for a mean of 8.4 years. These patients had survived an average of 5.5 years longer than their five respective homozygous siblings (p = 0.3), each of whom must have had a matching genetic defect but who died untreated. The 37% decrease in peak serum cholesterol concentrations maintained by plasma exchange presumably reduced progression of atherosclerosis in the treated patients and thus lessened their risk of premature death.
31
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
Tokuo Yamamoto, Christopher G. Davis, Michael S. Brown et al. · Cell · 1984 · 1.4K citations